These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 15197520

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Gender differences in nighttime plasma arginine vasopressin and delayed compensatory urine output in the elderly population after desmopressin.
    Hvistendahl GM, Frøkiaer J, Nielsen S, Djurhuus JC.
    J Urol; 2007 Dec; 178(6):2671-6. PubMed ID: 17945283
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Antidiuretic reaction of the human and rat kidney to peroral administration of arginine-vasopressin and desmopressin].
    Natochin IuV, Grigor'ev AI, Buravkova LB, Larina IM, Prutskova NP, Shakhmatova EI.
    Ross Fiziol Zh Im I M Sechenova; 2003 Feb; 89(2):184-92. PubMed ID: 12710188
    [Abstract] [Full Text] [Related]

  • 28. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M, Tempero K, Kirby M, Thompson J.
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis.
    Bosma R, Wynia K, Havlíková E, De Keyser J, Middel B.
    Acta Neurol Scand; 2005 Jul; 112(1):1-5. PubMed ID: 15932348
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics and antidiuretic effect of a new vasopressin analogue (F992) in overhydrated male volunteers.
    Callréus T, Lundahl J, Broeders A, Höglund P.
    Eur J Clin Pharmacol; 1999 Jun; 55(4):293-8. PubMed ID: 10424322
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study.
    Asplund R, Sundberg B, Bengtsson P.
    BJU Int; 1999 Apr; 83(6):591-5. PubMed ID: 10233563
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics and Pharmacodynamics of the Oral Disintegrating Tablet of Desmopressin in Adults with Nocturnal Polyuria: A Pilot Study.
    Goessaert AS, Everaert K, Hoebeke P, Vande Walle J.
    Adv Ther; 2015 Sep; 32(9):799-808. PubMed ID: 26412224
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of concentration and volume on nasal bioavailability and biological response to desmopressin.
    Harris AS, Ohlin M, Lethagen S, Nilsson IM.
    J Pharm Sci; 1988 Apr; 77(4):337-9. PubMed ID: 3379594
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Osmoregulation and desmopressin pharmacokinetics in enuretic children.
    Nevéus T.
    Scand J Urol Nephrol Suppl; 1999 Apr; 202():52. PubMed ID: 10573795
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.